These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23392330)

  • 1. Darkening of white hair in Parkinson's disease during use of levodopa rich Mucuna pruriens extract powder.
    Munhoz RP; Teive HA
    Arq Neuropsiquiatr; 2013 Feb; 71(2):133. PubMed ID: 23392330
    [No Abstract]   [Full Text] [Related]  

  • 2. Levodopa-Reduced
    Johnson SL; Park HY; DaSilva NA; Vattem DA; Ma H; Seeram NP
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30131460
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucuna pruriens for Parkinson's disease: Low-cost preparation method, laboratory measures and pharmacokinetics profile.
    Cassani E; Cilia R; Laguna J; Barichella M; Contin M; Cereda E; Isaias IU; Sparvoli F; Akpalu A; Budu KO; Scarpa MT; Pezzoli G
    J Neurol Sci; 2016 Jun; 365():175-80. PubMed ID: 27206902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of the antiparkinson drug Mucuna pruriens.
    Manyam BV; Dhanasekaran M; Hare TA
    Phytother Res; 2004 Sep; 18(9):706-12. PubMed ID: 15478206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Darkening of white hair following levodopa therapy in a patient with Parkinson's disease.
    Komagamine T; Suzuki K; Hirata K
    Mov Disord; 2013 Oct; 28(12):1643. PubMed ID: 24166898
    [No Abstract]   [Full Text] [Related]  

  • 6. Mucuna pruriens in Parkinson Disease: A Kinetic-Dynamic Comparison With Levodopa Standard Formulations.
    Contin M; Lopane G; Passini A; Poli F; Iannello C; Guarino M
    Clin Neuropharmacol; 2015; 38(5):201-3. PubMed ID: 26366963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could Mucuna pruriens be the answer to Parkinson's disease management in sub-Saharan Africa and other low-income countries worldwide?
    Fothergill-Misbah N; Maroo H; Cham M; Pezzoli G; Walker R; Cilia R
    Parkinsonism Relat Disord; 2020 Apr; 73():3-7. PubMed ID: 32179240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study.
    Katzenschlager R; Evans A; Manson A; Patsalos PN; Ratnaraj N; Watt H; Timmermann L; Van der Giessen R; Lees AJ
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1672-7. PubMed ID: 15548480
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kamkaen N; Chittasupho C; Vorarat S; Tadtong S; Phrompittayarat W; Okonogi S; Kwankhao P
    Molecules; 2022 May; 27(10):. PubMed ID: 35630617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Physicochemical Stability of the L-DOPA Extract of
    Vilairat C; Kobtrakul K; Vimolmangkang S
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
    Yadav SK; Prakash J; Chouhan S; Westfall S; Verma M; Singh TD; Singh SP
    Neurochem Int; 2014 Jan; 65():1-13. PubMed ID: 24333323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study.
    Cilia R; Laguna J; Cassani E; Cereda E; Raspini B; Barichella M; Pezzoli G
    Parkinsonism Relat Disord; 2018 Apr; 49():60-66. PubMed ID: 29352722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucuna Pruriens Combined with Carbidopa in Parkinson's Disease: A Case Report.
    Radder DLM; Tiel Groenestege AT; Boers I; Muilwijk EW; Bloem BR
    J Parkinsons Dis; 2019; 9(2):437-439. PubMed ID: 30856121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of an LC-MS/MS method for simultaneous quantification of levodopa and MD01 in rat plasma and its application to a pharmacokinetic study of mucuna pruriens extract.
    Yang G; Zhang F; Deng L; Chen C; Cheng Z; Huang J; Liu J; Jiang H
    Biomed Chromatogr; 2016 Sep; 30(9):1506-14. PubMed ID: 26928470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Parkinson botanical Mucuna pruriens prevents levodopa induced plasmid and genomic DNA damage.
    Tharakan B; Dhanasekaran M; Mize-Berge J; Manyam BV
    Phytother Res; 2007 Dec; 21(12):1124-6. PubMed ID: 17622977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Parkinson's disease in Ayurveda: Medicinal plants and adjuvant measures.
    Pathak-Gandhi N; Vaidya AD
    J Ethnopharmacol; 2017 Feb; 197():46-51. PubMed ID: 27544001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Levodopa Content in Commercial Mucuna pruriens Products Using High-Performance Liquid Chromatography with Fluorescence Detection.
    Soumyanath A; Denne T; Hiller A; Ramachandran S; Shinto L
    J Altern Complement Med; 2018 Feb; 24(2):182-186. PubMed ID: 28922612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of extract of Bacopa monnieri and Mucuna pruriens as neuroprotectant in MPTP model of Parkinson’s disease.
    Singh B; Pandey S; Verma R; Ansari JA; Mahdi AA
    Indian J Exp Biol; 2016 Nov; 54(11):758-66. PubMed ID: 30179419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiparkinson drug--Mucuna pruriens shows antioxidant and metal chelating activity.
    Dhanasekaran M; Tharakan B; Manyam BV
    Phytother Res; 2008 Jan; 22(1):6-11. PubMed ID: 18064727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases.
    Zahra W; Birla H; Singh SS; Rathore AS; Dilnashin H; Singh R; Keshri PK; Gautam P; Singh SP
    Neurochem Res; 2022 Jul; 47(7):1816-1829. PubMed ID: 35380400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.